Intraoperative Radiation for Pancreatic Cancer

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Pancreatic cancer (PDAC) presents significant treatment challenges with poor patient prognosis.
• Effective management of PDAC, including both resectable and unresectable cases, increasingly relies on local tumor control.
• Local recurrence and tumor progression are major contributors to morbidity and mortality in PDAC patients.

Purpose of the Study:

• To review the existing literature on the application of intraoperative radiation therapy (IORT) in pancreatic cancer.
• To evaluate the efficacy of IORT in improving local control for patients with resectable and unresectable PDAC.
• To highlight the benefits of IORT in delivering targeted radiation doses while minimizing toxicity to surrounding healthy tissues.

Main Methods:

• Comprehensive literature search of studies investigating intraoperative radiation therapy for pancreatic cancer.
• Analysis of data pertaining to local recurrence rates, survival outcomes, and toxicity profiles.
• Review of techniques for dose delivery and target localization in IORT for PDAC.

Main Results:

• Emerging evidence suggests that radiation dose escalation can enhance local control and survival in PDAC.
• Intraoperative radiation therapy allows for the delivery of higher radiation doses directly to the tumor or tumor bed.
• IORT effectively minimizes radiation exposure to adjacent radiosensitive organs, a key limitation of conventional external beam radiotherapy.

Conclusions:

• Intraoperative radiation therapy is a valuable tool for improving local control in both resectable and unresectable pancreatic cancer.
• The targeted delivery of radiation via IORT holds potential for enhancing therapeutic outcomes in PDAC management.
• Further research and clinical integration of IORT may offer improved survival and reduced morbidity for patients with pancreatic cancer.